• Publications
  • Influence
New Appendix Criteria Open for a Broader Concept of Chronic Migraine
The International Headache Classification Committee has worked out the more inclusive criteria for CM and MOH and it is now recommended that the MOH diagnosis should no longer request improvement after discontinuation of medication overuse but should be given to patients if they have a primary headache plus ongoing medication over use. Expand
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review)
This practice parameter summarizes the results from the four evidence-based reviews on the management of patients with migraine: specifically, acute, preventive, and nonpharmacologic treatments for migraine, and the role of neuroimaging in patients with headache. Expand
Cutaneous allodynia in the migraine population
To develop and validate a questionnaire for assessing cutaneous allodynia (CA), and to estimate the prevalence and severity of CA in the migraine population.
Classification of daily and near-daily headaches
Primary chronic daily headache can be subdivided into transformed migraine, chronic tension-type headache, hemicrania continua, and new daily persistent headache. We proposed and tested criteria inExpand
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study
The results of this feasibility study offer promise and should prompt further controlled studies of occipital nerve stimulation (ONS) in CM. Expand
Premonitory symptoms in migraine
Using an electronic diary system, the authors show that migraineurs who report premonitory symptoms can accurately predict the full-blown headache. Expand
Topiramate in migraine prevention: results of a large controlled trial.
Topiramate, 100 or 200 mg/d, was effective as a preventive therapy for patients with migraine and eliminated paresthesia, fatigue, nausea, anorexia, and taste per version. Expand
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults
Divalproex sodium, sodium valproate, topiramate, metoprolol, propranolol, and timolol are effective for migraine prevention and should be offered to patients with migraine to reduce migraine attack frequency and severity. Expand
Fremanezumab for the Preventive Treatment of Chronic Migraine
Fremanezumab as a preventive treatment for chronic migraine resulted in a lower frequency of headache than placebo in this 12‐week trial, and the long‐term durability and safety of fremanzumab require further study. Expand